PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G‐CSF mobilization

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 125-132

John Wiley & Sons Inc

Access to resources Recommend Favorite

P-selectin glycoprotein ligand-1 deficiency augments G-CSF induced myeloid cell mobilization

By Miszti-Blasius Kornél   Felszeghy Szabolcs   Kiss Csongor   Benkő Ilona   Géresi Krisztina   Megyeri Attila   Hevessy Zsuzsanna   Kappelmayer János  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 2, 2014-02 ,pp. : 109-118

Springer Publishing Company

Access to resources Recommend Favorite

G-CSF reduces febrile neutropenia and mortality risk

By  

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Plerixafor: A Review of its Use in Stem-Cell Mobilization in Patients with Lymphoma or Multiple Myeloma

By Keating Gillian M.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1623-1647

Adis International

Access to resources Recommend Favorite